All‐cause mortality · people with traumatic head injuries
It is very uncertain whether antiepileptic drugs changes all‐cause mortality compared with placebo or standard care (very low certainty).
1 finding from 1 review
All‐cause mortality · people with traumatic head injuries
Neuroprotective agent showed no clear difference in all‐cause mortality compared with placebo (high certainty).
1 finding from 1 review
All cause mortality · patients with afebrile neutropenia induced by chemotherapy
Summary of findings: antibiotics leads to lower all cause mortality compared with placebo or no intervention (high certainty).
1 finding from 1 review
Early all‐cause mortality (within 30 days) · adults undergoing non‐cardiac surgery under general anaesthesia (to include: low‐risk, medium‐risk, and high‐risk surgeries)
Perioperative beta‐blockers showed no clear difference in early all‐cause mortality (within 30 days) compared with placebo or standard care (low certainty).
1 finding from 1 review
Mortality before hospital discharge · preterm infants receiving nasal CPAP
Bubble showed no clear difference in all‐cause mortality before hospital discharge compared with ventilator or Infant Flow Driver nasal continuous positive airway… (low certainty).
1 finding from 1 review
Mortality at 8 weeks · adults living with HIV
Effect of LF‐LAM probably leads to lower mortality at 8 weeks compared with no LF‐LAM on mortality and tuberculosis treatment initiation (moderate certainty).
1 finding from 1 review
Coronary heart disease mortality – CHD deaths · adults with or without existing CVD
High showed no clear difference in coronary heart disease mortality – CHD deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
1 finding from 1 review
Coronary heart disease mortality – CHD deaths · adults with or without existing CVD
High showed no clear difference in coronary heart disease mortality – CHD deaths compared with low long‐chain omega‐3 fats (low certainty).
1 finding from 1 review
Mortality (respiratory‐ related and all‐cause · adults with acute exacerbations of chronic obstructive pulmonary disease
Titrated oxygen therapy may leads to lower mortality (respiratory‐ related and all‐cause compared with high‐flow oxygen therapy (low certainty).
1 finding from 1 review
Intervention not reported
Procedural mortality · Individuals with peripheral arterial disease
The intervention showed no clear difference in procedural mortality (high certainty).
1 finding from 1 review
Mortality (to end of · post‐exacerbation COPD
Pulmonary rehabilitation showed no clear difference in mortality (to end of compared with usual care (low certainty).
1 finding from 1 review
All‐cause mortality at 100 days post‐transplant · Patients undergoing stem cell transplant with malignant and non‐malignant diseases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular mortality · adults with or without existing CVD
High showed no clear difference in cardiovascular mortality – cardiovascular deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · adults with or without existing CVD
High probably leads to lower cardiovascular mortality – cardiovascular deaths compared with low long‐chain omega‐3 fats (moderate certainty).
1 finding from 1 review
All‐cause mortality ( · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
It is very uncertain whether intramuscular injection of bone marrow mononuclear cells (BMMNC) changes all‐cause mortality ( compared with control (very low certainty).
1 finding from 1 review
Change in Infant Mortality Rate per 1000 live births1 · children U5
It is very uncertain whether summary of findings: integrated community case management changes infant mortality rate compared with usual facility services (very low certainty).
1 finding from 1 review
HR 0.98 [0.72, 1.34]
65209 participants
Very low
Mortality at 6 months · adults living with HIV
Effect of LF‐LAM showed no clear difference in mortality at 6 months compared with no LF‐LAM on mortality and tuberculosis treatment initiation (low certainty).
1 finding from 1 review
In‐hospital mortality · people undergoing pancreaticoduodenectomy
1 finding from 1 review
In‐hospital mortality · people undergoing pancreaticoduodenectomy
Stents showed no clear difference in in‐hospital mortality compared with no stents (moderate certainty).
1 finding from 1 review
In‐hospital mortality · people undergoing pancreaticoduodenectomy
Internal stents showed no clear difference in in‐hospital mortality compared with external stents (low certainty).
1 finding from 1 review